Hyponatraemia as an adverse drug reaction of antipsychotic drugs: A case-control study in VigiBase

Drug Safety

Volumn 33, Issue 7, 2010, Pages 569-578

  Mannesse, Cyndie K ^a   Van Puijenbroek, Eugéne P ^b   Jansen, Paul A F ^c   Van Marum, Rob J ^c   Souverein, Patrick C ^d   Egberts, Toine C G ^c,d  

^a Vlietland Hospital   (Netherlands)

^b NETHERLANDS PHARMACOVIGILANCE CENTRE LAREB   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Adverse reactions; Adverse reaction monitoring; Antipsychotics; Clozapine; Dopamine D2 receptor modulators; Drug induced; Hyponatraemia; Inappropriate antidiuretic hormone secretion

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; CYAMEMAZINE; DOPAMINE 2 RECEPTOR; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LEVOMEPROMAZINE; LOXAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PIPAMPERONE; PROCHLORPERAZINE; QUETIAPINE; RISPERIDONE; SEROTONIN 2A RECEPTOR; SULPIRIDE; THIORIDAZINE; TIAPRIDE; TRIFLUOPERAZINE; ZIPRASIDONE; ZUCLOPENTHIXOL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DRUG SAFETY; DRUG STRUCTURE; DRUG SURVEILLANCE PROGRAM; DRUG USE; FEMALE; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR AFFINITY; SEX DIFFERENCE; CHEMICALLY INDUCED; MIDDLE AGED; NETHERLANDS; WORLD HEALTH ORGANIZATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPONATREMIA; MALE; MIDDLE AGED; NETHERLANDS; WORLD HEALTH ORGANIZATION;

EID: 77953575264     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11532560-000000000-00000     Document Type: Article

References (69)

1. Tomson CR. Neuroleptic malignant syndrome associated with inappropriate antidiuresis and psychogenic poly-dipsia. Br Med J (Clin Res Ed) 1986; 292 (6514): 171
2. Vucicevic Z, Degoricija V, Alfirevic Z, et al. Fatal hypona-tremia and other metabolic disturbances associated with psychotropic drug polypharmacy. Int J Clin Pharmacol Ther 2007; 45 (5): 289-293
3. Wetterling T. Hyponatriaemia: an underdiagnosed compli-cation in the treatment of psychiatric patients. Nervenarzt 1987 Oct; 58 (10): 625-631
4. deLeon J. Polydipsia: a study in a long-term psychiatric unit. Eur Arch Psychiatry Clin Neurosci. 2003 Feb. 253(1), 37-39
5. Riggs AT, Dysken MW, Kim SW, et al. A review of dis-orders of water homeostasis in psychiatric patients. Psy-chosomatics 1991; 32 (2): 133-148
6. Thomas A, Verbalis JG. Hyponatremia and the syndrome of inappropriate antidiuretic hormone secretion associated with drug therapy in psychiatric patients. CNS Drugs 1995; 4 (5): 357-369
7. Lydakis C, Apostolakis S, Thalassinos E, et al. PIP syndrome: a potentially threatening manifestation of a psychiatric disorder. Int J Clin Pract 2005; 59 (5): 612-613
8. Vieweg WV, Carey RM, Godleski LS, et al. The syndrome of psychosis, intermittent hyponatremia, and polydipsia: evidence for diurnal volume expansion. Psychiatr Med 1990; 8 (4): 135-144
9. Gillum DM, Linas SL. Water intoxication in a psychotic patient with normal renal water excretion. Am J Med 1984 Oct; 77 (4): 773-774
10. Peck V, Shenkman L. Haloperidol-induced syndrome of inappropriate secretion of antidiuretic hormone. Clin Pharmacol Ther 1979 Oct; 26 (4): 442-444
11. Ajlouni K, Kern MW, Tures JF, et al. Thiothixene-induced hyponatremia. Arch Intern Med 1974 Dec; 134 (6): 1103-1105
12. Cadnapaphornchai MA, Summer SN, Falk S, et al. Effect of primary polydipsia on aquaporin and sodium transporter abundance. Am J Physiol Renal Physiol 2003 Nov; 285 (5): F965-71
13. Hariprasad MK, Eisinger RP. SIADH in psychosis [letter]. J Clin Psychiatry 1980 Apr; 41 (4): 148
14. Goldman MB, Luchins DJ, Robertson GL. Mechanisms of altered water metabolism in psychotic patients with poly-dipsia and hyponatremia. N Engl J Med 1988 Feb 18; 318 (7): 397-403
15. Goldman MB, Robertson GL, Luchins DJ, et al. The in-fluence of polydipsia on water excretion in hyponatremic, polydipsic, schizophrenic patients. J Clin Endocrinol Metab 1996 Apr; 81 (4): 1465-1470
16. Atalay A, Turhan N, Aki OE. A challenging case of syn-drome of inappropriate secretion of antidiuretic hormone in an elderly patient secondary to quetiapine. South Med J 2007 Aug; 100 (8): 832-833
17. van den Heuvel OA, Bet PM, van Dam EW, et al. The syn-drome of inappropriate antidiuretic hormone secretion (SIADH) during treatment with the antipsychotic agents haloperidol and quetiapine. Ned Tijdschr Geneeskd 2006 Sep 2; 150 (35): 1944-1948
18. Bachu K, Godkar D, Gasparyan A, et al. Aripiprazole-induced syndrome of inappropriate antidiuretic hormone secretion (SIADH). Am J Ther 2006 Jul-Aug; 13 (4): 370-372
19. Collins A, Anderson J. SIADH induced by two atypical antipsychotics. Int J Geriatr Psychiatry 2000; 15 (3): 282-283
20. Whitten JR, Ruehter VL. Risperidone and hyponatremia: a case report. Ann Clin Psychiatry 1997 Sep; 9 (3): 181-183
21. Rider JM, Mauger TF, Jameson JP, et al. Water handling in patients receiving haloperidol decanoate. Ann Pharma-cother 1995 Jul-Aug; 29 (7-8): 663-666
22. Spigset O, Hedenmalm K. Hyponatraemia and the syn-drome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs. Drug Saf 1995 Mar; 12 (3): 209-225
23. Ananth J, Lin KM. SIADH: a serious side effect of psychotropic drugs. Int J Psychiatry Med 1986; 16 (4): 401-407
24. Kimelman N, Albert SG. Phenothiazine-induced hypona-tremia in the elderly. Gerontology 1984; 30 (2): 132-136
25. Meulendijks D, Mannesse CK, Jansen PAF, et al. Anti-psychotic-induced hyponatremia: a systematic review of the published evidence. Drug Saf 2010; 33 (2): 101-114
26. Jessani M, Montgomery J, Fedde JD, et al. Lack of association between antipsychotics and hyponatremia in chronic schizophrenia. Schizophr Res 2006 Apr; 83 (2-3): 307-309
27. Spigset O, Hedenmalm K. Hyponatremia during treatment with clomipramine, perphenazine, or clozapine: study of therapeutic drug monitoring samples. J Clin Psycho-pharmacol 1996 Oct; 16 (5): 412-414
28. Vieweg WVR, Leadbetter RA. Polydipsia-hyponatraemia syndrome: epidemiology, clinical features and treatment. CNS Drugs 1997; 7 (2): 121-138
29. Kohen I, Voelker S, Manu P. Antipsychotic-induced hypo-natremia: case report and literature review. Am J Ther 2008; 15: 492-494
30. World Health Organization [online]. Available from URL: http://www.who.int/[Accessed 2010 Apr 21]
31. Lindquist M. VigiBase, the WHO global ICSR database system: basic facts. Drug Inf J 2008; 42: 408-419
32. KNMP. Informatorium medicamentorum [online]. Avail-able from URL: www.knmp.nl/vakinhoud/farmacotherapie/informatorium-medicamentorum [Accessed 2010 Apr 21]
33. Richtand NM, Welge JA, Logue AD, et al. Dopamine and serotonin receptor binding and antipsychotic efficacy. Neuropsychopharmacology 2007; 32: 1715-1726
34. Ma R, Kong A, Chan N, et al. Drug-induced endocrine and metabolic disorders. Drug Saf 2007; 30 (3): 215-245
35. Egberts ACG, Meyboom RHB, van Puijenbroek EP. Use of measures of disproportionality in pharmacovigilance: three Dutch examples. Drug Saf 2002; 25 (6): 453-458
36. van Puijenbroek EP, Bate A, Leufkens HGM, et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 2002; 11: 3-10
37. Weber JCP. Epidemiology of adverse reactions to nonsteroidal antiinflammatory drugs. In: Rainsford KD, Velo GP, editors. Advances in inflammatory research. New York: Raven Press, 1984: 1-7
38. Lim JK, Yap KB. Hyponatraemia in hospitalised elderly patients. Med J Malaysia 2001; 56 (2): 232-235
39. Chua M, Hoyle GE, Soiza RL. Prognostic implications of hyponatremia in elderly hospitalized patients. Arch Gerontol Geriatr 2007; 45 (3): 253-258
40. O'Connor KA, Cotter PE, Kingston M, et al. The pattern of plasma sodium abnormalities in an acute elderly care ward: a cross-sectional study. Ir J Med Sci 2006; 175 (3): 28-31
41. Zilberberg MD, Exuzides A, Spalding J, et al. Epidemiol-ogy, clinical and economic outcomes of admission hypo-natremia among hosptitalized patients. Curr Med Res Opin 2008; 24 (6): 1601-1606
42. Leadbetter RA, Shutty Jr MS. Differential effects of neuroleptics and clozapine on polydipsia and intermittent hyponatremia. J Clin Psychiatry 1994; 55 (9 Suppl. B): 110-113
43. Spears NM, Leadbetter RA, Shutty Jr MS. Clozapine treatment in polydipsia and intermittent hyponatremia. J Clin Psychiatry 1996; 57 (3): 123-128
44. Leadbetter RA, Shutty MS. Differential effects of neuro-leptics and clozapine on polydipsia and intermittent hypo-natremia. J Clin Psychiatry 1994; 55 (9): 110-113
45. Canuso CM, Goldman MB. Clozapine restores water balance in schizophrenic patients with polydipsia-hyponatremia syndrome. J Neuropsychiatry Clin Neurosci 1999; 11 (1): 86-90
46. Littrell KH, Johnson CG, Littrell SH, et al. Effects of olanzapine on polydipsia and intermittent hyponatremia [letter]. J Clin Psychiatry 1997; 58 (12): 549
47. Kruse D, Pantelis C, Rudd R, et al. Treatment of psycho-genic polydipsia: comparison of risperidone and olanza-pine, and the effects of an adjunctive angiotensin-II receptor blocking drug (irbesartan). Aust N Z J Psychiatry 2001; 35 (1): 65-68
48. Kar N, Sharma PS, Tolar P, et al. Polydipsia and risper-idone. Aust N Z J Psychiatry 2002 Apr; 36 (2): 268-270
49. Montgomery JH, Tekell JL. Adjunctive quetiapine treat-ment of the polydipsia, intermittent hyponatremia, and psychosis syndrome: a case report. J Clin Psychiatry 2003 Mar; 64 (3): 339-341
50. Ginsberg DL. Aripriprazole-induced hyponatremia. Prim Psychiatry 2007; 14 (6): 19-22
51. Madhusoodanan S, Bogunovic OJ, Moise D, et al. Hypo-natraemia associated with psychotropic medications: a review of the literature and spontaneous reports. Adverse Drug React Toxicol Rev 2002; 21 (1-2): 17-29
52. Raskind MA, Courtney N, Murburg MM, et al. Anti-psychotic drugs and plasma vasopressin in normals and acute schizophrenic patients. Biol Psychiatry 1987 Apr; 22 (4): 453-462
53. de Rivera JL. Letter: inappropriate secretion of antidiuretic hormone from fluphenazine therapy. Ann Intern Med 1975 Jun; 82 (6): 811-812
54. Cordoba OA, Chapel JL. Syndrome of inappropriate se-cretion of antidiuretic hormone (SIADH) secondary to antipsychotic drug therapy: case report. Mo Med 1978 Apr; 75 (4): 177-8, 81
55. Vincent FM, Emery S. Antidiuretic hormone syndrome and thioridazine. Ann Intern Med 1978 Jul; 89 (1): 147-148
56. Caron C, Shooner K, Martneau M. Water intoxication in a schizophrenic patient under treatment with thioridazine: study of the physiopathological mechanisms involved. Union Med Liege 1979; 108: 1078-1082
57. Nardelli E, Luzzani A. Water intoxication from fluphena-zine therapy. Ital J Neurol Sci 1980 Jun; 1 (3): 193-196
58. Husband C, Mai FM, Carruthers G. Syndrome of inappropriate secretion of anti-diuretic hormone in a patient treated with haloperidol. Can J Psychiatry 1981; 26 (3): 196-197
59. Glusac E, Patel H, Josef NC, et al. Polydipsia and hypona-tremia induced by multiple neuroleptics but not mo-lindone. Can J Psychiatry 1990 Apr; 35 (3): 268-269
60. Korzets A, Ori Y, Floro S, et al. Case report: severe hyponatremia after water intoxication. A potential cause of rhabdomyolysis. Am J Med Sci 1996 Aug; 312 (2): 92-94
61. Ben-Aryeh H, Jungerman T, Szargel R, et al. Salivary flow-rate and composition in schizophrenic patients on clozapine: subjective reports and laboratory data. Biol Psychiatry 1996 Jun 1; 39 (11): 946-949
62. Ma RCW, Kong APS, Chan N, et al. Drug-induced endo-crine and metabolic disorders. Drug Saf 2007; 30 (3): 215-245
63. Liamis G, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis 2008; 52 (1): 144-153
64. Alvarez-Requejo A, Carvajal A, Begaud B, et al. Under-reporting of adverse drug reactions: estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol 1998 August; 54 (6): 433-438
65. Moore N, Hall G, Sturkenboom M, et al. Biases affecting the proportional reporting ratio (PPR) in spontaneous reports pharmacovigilance databases: the example of ser-tindole. Pharmacoepidemiol Drug Saf 2003; 12 (4): 271-281
66. Pariente A, Gregoire F, Fourrier-Reglat A, et al. Impact of safety alerts on measures of disproportionality in spon-taneous reporting databases: the notoriety bias. Drug Saf 2007; 30 (10): 891-898
67. Heijden PGM, van Puijenbroek EP, van Buuren S, et al. On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under-reporting on odds ratios. Stat Med 2002; 21 (14): 2027-2044
68. Horwitz RI, Feinstein AR. The problem of "protopathic bias" in case-control studies. Am J Med 1980; 68 (2): 255-258
69. Hoorn EJ, Halperin ML, Zietse R. Diagnostic approach to a patient with hyponatremia: traditional versus physiology-based options. Q J Med 2005; 98: 529-540